ESR1 and breast cancer: Furthermore, studies have demonstrated a significant correlation between the higher expression of FXR and estrogen receptors (ER), particularly in the context of breast cancer in postmenopausal patients [89], suggesting that the absence of estrogens may reveal the association between FXR and cell proliferation.